European Perspective on Biosimilars

J Oncol Pract. 2017 Sep;13(9_suppl):15s-16s. doi: 10.1200/JOP.2017.025569.
No abstract available

MeSH terms

  • Antibodies, Monoclonal
  • Biological Products*
  • Biosimilar Pharmaceuticals*
  • Drug Utilization
  • Europe
  • Hematinics

Substances

  • Antibodies, Monoclonal
  • Biological Products
  • Biosimilar Pharmaceuticals
  • Hematinics